No headlines found.
Biote Reports Fourth Quarter and Full Year 2025 Financial Results
Business Wire (Wed, 11-Mar 4:05 PM ET)
Biote Schedules Fourth Quarter and Full Year 2025 Financial Results Release and Conference Call
Business Wire (Wed, 25-Feb 4:10 PM ET)
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
Biote Corp. - Class A trades on the NASDAQ stock market under the symbol BTMD.
As of April 9, 2026, BTMD stock price climbed to $1.49 with 198,817 million shares trading.
BTMD has a beta of 1.25, meaning it tends to be more sensitive to market movements. BTMD has a correlation of 0.11 to the broad based SPY ETF.
BTMD has a market cap of $45.76 million. This is considered a Sub-Micro Cap stock.
Last quarter Biote Corp. - Class A reported $46 million in Revenue and $.06 earnings per share. This beat revenue expectation by $638,120 and missed earnings estimates by -$.02.
In the last 3 years, BTMD traded as high as $8.44 and as low as $1.27.
The top ETF exchange traded funds that BTMD belongs to (by Net Assets): VTI, IWM, VXF, VTWO, IWN.
BTMD has underperformed the market in the last year with a price return of -54.2% while the SPY ETF gained +38.5%. BTMD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -41.1% and +3.5%, respectively, while the SPY returned -1.1% and +3.6%, respectively.
BTMD support price is $1.37 and resistance is $1.57 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BTMD shares will trade within this expected range on the day.
